Register
Login:
Share:
Email Facebook Twitter

Michael Masterman introduces Saffron Energy to London AIM Market (LON: SRON) Watch here

Michael Masterman introduces Saffron Energy to London AIM Market (LON: SRON)


Futura Medical Share Chat (FUM)



Share Price: 53.00Bid: 0.00Ask: 0.00Change: 0.00 (0.00%)No Movement on Futura Med.
Spread: 0.00Spread as %: 0.00%Open: 53.00High: 0.00Low: 0.00Yesterday’s Close: 53.00


Share Discussion for Futura Medical


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Mrmacduff
Posts: 13
Off Topic
Opinion:No Opinion
Price:53.00
Zwartkops
Mon 22:01
No mate , the erectogenic gel will be in a 6 billion market which fum are hoping for a slice of .
 
Zwartkops
Posts: 105
Observation
Opinion:Strong Buy
Price:53.00
From another board..Interesting
Mon 19:31
77j: Hype?Totally disagree.The co is looking to around $600,000,000 worth of condom sales in the next few yearsUpon which they will be receiving substantial recurring revenues in the form of royalties.The pain gel markets are even greaterThe erectogenic gel,could address a market worth hundreds of millions of dollars,if not more.New product development will bring new markets to fum.I see £10 to £20 share price in the next five years.Gla.
Whiterhino
Posts: 111
Off Topic
Opinion:No Opinion
Price:55.50
RE: March 23rd Preliminary Results
20 Feb '17
That's a great question. No reason to believe of course that the initial royalty agreement/payment hasn't been triggered yet, but you would think such a significant statement/event would have to be in there.
B2HS2L
Posts: 48
Research
Opinion:Strong Buy
Price:55.50
March 23rd Preliminary Results
20 Feb '17
I am looking for evidence of income from Royalties and Agreements in the March 23rd 2017 Prelim. results.

Below is an extract from the FUM Interim Results published 13.09.2016.

Bottom of Page 3 -

"Commercial manufacture of product for the launch of CSD500 in the first Middle East country, where
regulatory approval has already been granted, has already taken place with the launch expected later this
year.
The initial royalty payment has already been received for this and will be recognised upon launch.
We anticipate further launches of the product in other territories during 2017."

CSD500 recently launched in Saudi-Arabia, so I am assuming the royalty payments will be visible in the accounts.
Hopefully there will be info about amount of initial sales.

1) It will show the market FUM has a royalties income stream for the first time.

2) It might prompt the business press to articulate more often on FUM progress, and help to stabilise /improve the share price.

Lets hope the market likes the numbers.
GCCRa
Posts: 347
Off Topic
Opinion:Strong Buy
Price:54.00
James Barder
17 Feb '17
James Barder = Top Man.

You won't get many CEO's responding at all to shareholders, no-matter so quickly.

Well done Mr B and Chariot for asking the question.

Encouraging indeed. As you say, an announcement will come without warningSP will rocket with no time to respond. Best top up now I think !
Suark
Posts: 13
Off Topic
Opinion:No Opinion
Price:54.00
Chariot
17 Feb '17
Thanks for taking the time to post his reply, and well done to Mr. Barder for the info. Appreciate he can't be too specific.
Zwartkops
Posts: 105
Off Topic
Opinion:Strong Buy
Price:54.00
RE: Message from James Barder
17 Feb '17
Wow That answers so many questions...well done chariot...best news for months.
SuperRoty
Posts: 104
Off Topic
Opinion:Strong Buy
Price:54.00
RE: Message from James Barder
17 Feb '17
Great thanks Chariot for the update.

As I suspect this may take off without warning.
Chariot
Posts: 135
Off Topic
Opinion:No Opinion
Price:54.00
Message from James Barder
17 Feb '17
I wrote to FUM this morning asking why there is not much product launch or promotions of CSD 500 condoms though they have 8 licenses covering almost everywhere, within an hour James Barder replied me:

"In respect of your concerns over other CSD500 launches. We are actively working on all these launches however in a number of instances, for example China and South Korea, this still requires regulatory approval. In EU territories launch plans are progressing and we will update shareholders as soon as we can however there are considerable commercial sensitivities here and our partners understandably do not want us to flag their intentions to potential competitors ahead of launch.
Regards
James Barder
CEO
Futura Medical plc
handybrownone
Posts: 418
Off Topic
Opinion:No Opinion
Price:54.00
RE: Time and money
16 Feb '17
PE and pharma is the kiss of death - Valeant - Concordia - just left one pharma where PE came in. Stada are not going to buy this




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.